If you are interested in the interface between cancer immunotherapy innovation and photonics, then catch up with Tomas Hode, PhD, co-founder, CIO, and President of Immunophotonics, Inc. in person at SPIE, the international society for optics and photonics conferences #PhotonicsWest / #BiOS 2022 Jan 22 – 27 in San Francisco. He and Lu Alleruzzo (CEO) are particularly interested to hear about the latest on PTT and nanomaterials use in oncology. Check out what we are doing at www.immunophotonics.com and feel free to contact us in advance to set up a meeting.

#ablation #immunooncology #innovation #immunotherapy